Weaker expectations for the oil & gas business
07/11/19 -"This led to an impairment (92% for goodwill) on the former Rhodia and Chemlogics activities (Novecare – Advance Formulations), which damaged the Q3 figures and came fully out of the blue. In ..."
Pages
52
Language
English
Published on
07/11/19
You may also be interested by these reports :
18/11/19
We understand k+s manoeuvres in an environment which can be impacted by many triggers, and we see the announcement of maintenance standstills cutting ...
13/11/19
Lanxess seems to have left the path of strong cyclicality and the respective impact on profitability. Nevertheless, the company could not completely ...
12/11/19
The discrepancy between H1 US-GAAP and IFRS accounts was not dramatic, but we continue to use European accounting standards as our universe is based ...
07/11/19
We have made some adjustments to take into account the huge impairment and added some first costs (€120m for 2019-21) in the implementation of the ...